Impella®, Percutaneous Left Ventricular Assist Device for Cardiogenic Shock

Our Experiences

Abstract

We report the outcome of patients supported with the Impella device at our institution. Similar to the interim analysis of J-PVAD registry presented at the 84th Annual Scientific Meeting of the Japanese Circulation Society, we observed a worse outcome in patients with AMI cardiogenic shock who received late Impella support. It is also important to highlight that only one patient of this cohort received Impella support before reperfusion at our institute. A door to unloading strategy as opposed to one emphasizing door to balloon combined with earlier initiation of Impella support seems promising¹⁾ and it the creation of a system that embraces door to unloading which is both our institute’s challenge and opportunity to improve outcomes.